Dingdang Health Technology Group (9886.HK) Stock Price

Dingdang Health Technology Group Price

CLOSED
0.69CNY+0.06 (+8.99 %)
Market closed

Over the last 7 years Dingdang Health Technology Group grew revenue by 37.6% annually, reaching 5.68 B CNY. For Dingdang Health Technology Group, the net margin of -1.0% is up versus -42.9% a few years ago. The consensus 12-month price target for Dingdang Health Technology Group is 1.37 CNY, about 99.5% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 13% above its 52-week low.

Dingdang Health Technology Group stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Dingdang Health Technology Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Dingdang Health Technology Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Dingdang Health Technology Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Dingdang Health Technology Group Stock Price History
DateDingdang Health Technology Group Price
8/25/20260.69 CNY
8/24/20260.63 CNY
8/21/20260.67 CNY
8/20/20260.69 CNY
8/19/20260.71 CNY
8/18/20260.71 CNY
8/17/20260.71 CNY
8/14/20260.66 CNY
8/13/20260.65 CNY
8/12/20260.65 CNY
8/11/20260.65 CNY
8/10/20260.65 CNY
8/7/20260.63 CNY
8/6/20260.63 CNY
8/5/20260.66 CNY
8/4/20260.62 CNY
8/3/20260.65 CNY
7/31/20260.65 CNY
7/30/20260.66 CNY
7/29/20260.67 CNY
7/28/20260.70 CNY
7/27/20260.70 CNY
7/24/20260.70 CNY
7/23/20260.69 CNY
7/22/20260.73 CNY
7/21/20260.75 CNY
7/20/20260.78 CNY
7/17/20260.79 CNY
7/16/20260.77 CNY
7/15/20260.80 CNY
7/14/20260.79 CNY
7/13/20260.81 CNY
7/10/20260.80 CNY
7/9/20260.84 CNY
7/8/20260.80 CNY
7/7/20260.82 CNY
7/6/20260.81 CNY
7/3/20260.82 CNY
7/2/20260.78 CNY
6/30/20260.82 CNY
6/29/20260.82 CNY
6/26/20260.80 CNY
6/25/20260.81 CNY
6/24/20260.81 CNY
6/23/20260.76 CNY
6/22/20260.83 CNY
6/18/20260.84 CNY
6/17/20260.82 CNY
6/16/20260.81 CNY
6/15/20260.80 CNY
6/12/20260.79 CNY
6/11/20260.78 CNY
6/10/20260.76 CNY
6/9/20260.76 CNY
6/8/20260.75 CNY
6/5/20260.74 CNY
6/4/20260.72 CNY
6/3/20260.73 CNY
6/2/20260.70 CNY
6/1/20260.74 CNY
5/29/20260.72 CNY
5/28/20260.69 CNY
5/27/20260.75 CNY
5/26/20260.76 CNY
5/22/20260.80 CNY
5/21/20260.78 CNY
5/20/20260.80 CNY
5/19/20260.80 CNY
5/18/20260.82 CNY
5/15/20260.87 CNY
5/14/20260.87 CNY
5/13/20260.83 CNY
5/12/20260.81 CNY
5/11/20260.85 CNY
5/8/20260.87 CNY
5/7/20260.90 CNY
5/6/20260.90 CNY
5/5/20260.89 CNY
5/4/20260.89 CNY
4/30/20260.92 CNY
4/29/20260.89 CNY
4/28/20260.92 CNY
4/27/20260.91 CNY
4/24/20260.90 CNY
4/23/20260.92 CNY
4/22/20260.96 CNY
4/21/20260.98 CNY
4/20/20260.96 CNY
4/17/20260.93 CNY
4/16/20260.92 CNY
4/15/20260.90 CNY
4/14/20260.88 CNY
4/13/20260.88 CNY
4/10/20260.87 CNY
4/9/20260.87 CNY
4/8/20260.84 CNY
4/2/20260.81 CNY
4/1/20260.81 CNY
3/31/20260.79 CNY
3/30/20260.77 CNY
3/27/20260.75 CNY
3/26/20260.75 CNY
3/25/20260.74 CNY
3/24/20260.73 CNY
3/23/20260.70 CNY
3/20/20260.71 CNY
3/19/20260.72 CNY
3/18/20260.68 CNY
3/17/20260.62 CNY
3/16/20260.63 CNY
3/13/20260.61 CNY
3/12/20260.63 CNY
3/11/20260.63 CNY
3/10/20260.62 CNY
3/9/20260.62 CNY
3/6/20260.63 CNY
3/5/20260.66 CNY
3/4/20260.64 CNY
3/3/20260.62 CNY
3/2/20260.65 CNY
2/27/20260.72 CNY
2/26/20260.71 CNY
2/25/20260.73 CNY
2/24/20260.77 CNY
2/23/20260.79 CNY
2/20/20260.80 CNY
2/16/20260.79 CNY
2/13/20260.78 CNY
2/12/20260.76 CNY
2/11/20260.78 CNY
2/10/20260.76 CNY
2/9/20260.76 CNY
2/6/20260.75 CNY
2/5/20260.74 CNY
2/4/20260.74 CNY
2/3/20260.80 CNY
2/2/20260.83 CNY
1/30/20260.85 CNY
1/29/20260.87 CNY
1/28/20260.87 CNY
1/27/20260.87 CNY
1/26/20260.87 CNY
1/23/20260.87 CNY
1/22/20260.88 CNY
1/21/20260.88 CNY
1/20/20260.92 CNY
1/19/20260.93 CNY
1/16/20260.94 CNY
1/15/20261.06 CNY
1/14/20261.06 CNY
1/13/20261.02 CNY
1/12/20261.02 CNY
1/9/20260.99 CNY
1/8/20260.97 CNY
1/7/20260.93 CNY
1/6/20260.93 CNY
1/5/20260.93 CNY
1/2/20260.91 CNY
12/31/20250.93 CNY
12/30/20250.91 CNY
12/29/20250.91 CNY
12/24/20250.98 CNY
12/23/20250.97 CNY
12/22/20250.98 CNY
12/19/20250.94 CNY
12/18/20250.91 CNY
12/17/20250.93 CNY
12/16/20250.92 CNY
12/15/20250.93 CNY
12/12/20250.93 CNY
12/11/20250.91 CNY
12/10/20250.91 CNY
12/9/20250.91 CNY
12/8/20250.91 CNY
12/5/20250.91 CNY
12/4/20250.92 CNY
12/3/20250.92 CNY
12/2/20250.92 CNY
12/1/20250.93 CNY
11/28/20250.93 CNY
11/27/20250.93 CNY
11/26/20250.93 CNY
11/25/20250.88 CNY
11/24/20250.89 CNY
11/21/20250.87 CNY
11/20/20250.89 CNY
11/19/20250.89 CNY
11/18/20250.93 CNY
11/17/20250.94 CNY
11/14/20251.01 CNY
11/13/20250.99 CNY
11/12/20251.03 CNY
11/11/20250.98 CNY
11/10/20250.97 CNY
11/7/20250.94 CNY
11/6/20250.96 CNY
11/5/20250.96 CNY
11/4/20250.92 CNY
11/3/20250.94 CNY
10/31/20250.98 CNY
10/30/20251.01 CNY
10/28/20251.02 CNY
10/27/20251.00 CNY
10/24/20250.95 CNY
10/23/20250.97 CNY
10/22/20251.01 CNY
10/21/20250.93 CNY
10/20/20250.94 CNY
10/17/20250.93 CNY
10/16/20250.95 CNY
10/15/20250.98 CNY
10/14/20250.95 CNY
10/13/20250.99 CNY
10/10/20251.00 CNY
10/9/20250.97 CNY
10/8/20251.04 CNY
10/6/20251.08 CNY
10/3/20250.84 CNY
10/2/20250.77 CNY
9/30/20250.69 CNY
9/29/20250.71 CNY
9/26/20250.68 CNY
9/25/20250.73 CNY
9/24/20250.71 CNY
9/23/20250.78 CNY
9/22/20250.67 CNY
9/19/20250.71 CNY
9/18/20250.70 CNY
9/17/20250.72 CNY
9/16/20250.74 CNY
9/15/20250.73 CNY
9/12/20250.76 CNY
9/11/20250.76 CNY
9/10/20250.75 CNY
9/9/20250.78 CNY
9/8/20250.71 CNY
9/5/20250.70 CNY
9/4/20250.68 CNY
9/3/20250.71 CNY
9/2/20250.68 CNY
9/1/20250.67 CNY
8/29/20250.69 CNY
8/28/20250.67 CNY
8/27/20250.68 CNY
Access this data via the Eulerpool API
Get Free API Key

Dingdang Health Technology Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
2.23 B CNY
-162.98 M CNY
-924.25 M CNY
Jan 1, 2021
3.68 B CNY
-660.65 M CNY
-1.58 B CNY
Jan 1, 2022
4.33 B CNY
-326.42 M CNY
-2.83 B CNY
Jan 1, 2023
4.86 B CNY
-278.25 M CNY
-225.81 M CNY
Jan 1, 2024
4.67 B CNY
-215.18 M CNY
-376.50 M CNY
Jan 1, 2025
5.68 B CNY
-62.13 M CNY
-56.98 M CNY
Jan 1, 2026 (e)
0.00 CNY
20.40 M CNY
39.68 M CNY
Jan 1, 2027 (e)
0.00 CNY
0.00 CNY
0.00 CNY

Dingdang Health Technology Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 7:05 AM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEB CNY
NET INCOME GROWTH%
SHARESB
201820192020202120222023202420252026e2027e
0.611.262.233.684.334.864.675.68––
–107.0877.2565.0817.7012.17-3.8521.67––
35.4236.8334.8333.6338.9231.1032.9435.26––
0.220.460.781.241.691.511.542.002.002.00
-67.00-116.00-162.00-660.00-326.00-278.00-215.00-62.0020.00–
-11.04-9.23-7.27-17.94-7.53-5.72-4.60-1.09––
-0.11-0.27-0.92-1.58-2.83-0.23-0.38-0.060.04–
–145.05239.7170.7879.53-92.0667.11-85.11-169.64–
1.301.300.260.801.051.341.321.301.301.30
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Dingdang Health Technology Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Dingdang Health Technology Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Dingdang Health Technology Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Dingdang Health Technology Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Dingdang Health Technology Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Dingdang Health Technology Group stock margins

The Dingdang Health Technology Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Dingdang Health Technology Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Dingdang Health Technology Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
34.86 %
-7.31 %
-41.47 %
Jan 1, 2021
33.65 %
-17.96 %
-42.90 %
Jan 1, 2022
38.94 %
-7.54 %
-65.45 %
Jan 1, 2023
31.10 %
-5.73 %
-4.65 %
Jan 1, 2024
32.95 %
-4.61 %
-8.06 %
Jan 1, 2025
35.26 %
-1.09 %
-1.00 %
Jan 1, 2026 (e)
35.26 %
- %
- %
Jan 1, 2027 (e)
35.26 %
0.00 %
0.00 %

Dingdang Health Technology Group Stock Revenue, EBIT, Earnings per Share

The Dingdang Health Technology Group earnings per share therefore indicates how much revenue Dingdang Health Technology Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
8.74 CNY
-0.64 CNY
-3.62 CNY
Jan 1, 2021
4.61 CNY
-0.83 CNY
-1.98 CNY
Jan 1, 2022
4.12 CNY
-0.31 CNY
-2.69 CNY
Jan 1, 2023
3.64 CNY
-0.21 CNY
-0.17 CNY
Jan 1, 2024
3.53 CNY
-0.16 CNY
-0.28 CNY
Jan 1, 2025
4.38 CNY
-0.05 CNY
-0.04 CNY
Jan 1, 2026 (e)
0.00 CNY
0.02 CNY
0.03 CNY
Jan 1, 2027 (e)
0.00 CNY
0.00 CNY
0.00 CNY

Dingdang Health Technology Group business model & stock analysis

Dingdang Health Technology Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Dingdang Health Technology Group historical P/E ratio, EBIT multiple, and P/S ratio

Dingdang Health Technology Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Dingdang Health Technology Group shares outstanding

The number of shares of Dingdang Health Technology Group was 1.3 B in 2025. This indicates how many shares Dingdang Health Technology Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
255.00 M Stocks
Jan 1, 2021
798.24 M Stocks
Jan 1, 2022
1.05 B Stocks
Jan 1, 2023
1.34 B Stocks
Jan 1, 2024
1.32 B Stocks
Jan 1, 2025
1.30 B Stocks
Jan 1, 2026 (e)
1.30 B Stocks
Jan 1, 2027 (e)
1.30 B Stocks

Current Dingdang Health Technology Group forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
85.71 % (6)
Hold
14.29 % (1)
Sell
0.00 % (0)
12M Price Target
1.37
Last Price
0.63
Currency
CNY
12M Return Potential
118.32 %
LTM Return
0 %

Dingdang Health Technology Group shareholder structure

% Name
0.02208%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.00091%
American Century Investment Management, Inc.
American Century Investment Management, Inc.
0.00000%
Phillip Capital Management (S) Ltd.
Phillip Capital Management (S) Ltd.

Dingdang Health Technology Group Beneficial Ownership Filings (SEC 13D/G)

Free Float
42.7%
Float Shares
-
Shares Outstanding
-

Dingdang Health Technology Group Executives and Management Board

11 members · avg. age 46 · 9 % women

WY

Mr. Wenlong Yang (60)

Executive Chairman of the Board, President · since 2014

236.38 M CNY

Management

LY

Mr. Lei Yu (45)

Vice President, Executive Director · since 2021

3.05 M CNY
QY

Mr. Qinglong Yu (37)

Chief Technology Officer, Executive Director · since 2021

2.54 M CNY
NX

Mr. Ning Xu (44)

Vice President, Executive Director · since 2021

1.97 M CNY
YL

Mr. Yiu Por Lam (47)

Chief Financial Officer, Joint Company Secretary

–
ZL

Mr. Zhenxuan Liu (37)

Joint Company Secretary

–

Board of Directors

YY

Mr. Yibin Yang (35)

Executive Director · since 2023

–
CL

Ms. Chuheng Li (33)

Non-Executive Director

–
ZF

Mr. Zhenhong Fan (54)

Independent Non-Executive Director

–
SJ

Mr. Shan Jiang (53)

Independent Non-Executive Director

–
SZ

Mr. Shouchuan Zhang (56)

Independent Non-Executive Director

–

Frequently asked questions about Dingdang Health Technology Group

Analysts currently set an average price target of 1.37 CNY for the Dingdang Health Technology Group stock (median: 1.37 CNY), implying +118.3 % versus the latest price. The consensus is based on 7 analyst ratings.

Dingdang Health Technology Group Analyst Price Targets 2026

7 analysts currently rate the Dingdang Health Technology Group stock: 6 recommend buying, 1 holding and 0 selling.

Dingdang Health Technology Group Analyst Price Targets 2026

Converted at the current exchange rate, the Dingdang Health Technology Group share trades at 0.09 EUR (0.69 CNY).

No history available for Dingdang Health Technology Group.

The revenue cannot currently be calculated for Dingdang Health Technology Group.

The expected profit of Dingdang Health Technology Group is 39.68 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Dingdang Health Technology Group is currently 22.44. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Dingdang Health Technology Group stock.

The P/S cannot be calculated for Dingdang Health Technology Group currently.

The Eulerpool Quality Score for Dingdang Health Technology Group is 3/10.

The ISIN of Dingdang Health Technology Group is KYG2762W1069. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Dingdang Health Technology Group is 9886.HK. The ticker symbol is used to trade Dingdang Health Technology Group shares on the stock exchange.

Dingdang Health Technology Group paid dividends every year for the past 0 years.

Dingdang Health Technology Group is assigned to the 'Non-cyclical consumption' sector.

The dividends of Dingdang Health Technology Group are distributed in CNY.

All fundamentals and in-depth analysis of Dingdang Health Technology Group

Our stock analysis for Dingdang Health Technology Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dingdang Health Technology Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Dingdang Health Technology Group Stock
Dingdang Health Technology Group Revenue→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Net Income→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group P/E→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group P/S→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group EBIT→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Dividend→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Directors Dealings→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Stocks→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Market capitalization→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Debt→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Liabilities→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Equity→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group AAQS→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Employees→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group ROE→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group ROA→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group ROCE→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group News→
Dingdang Health Technology Group Stock
Dingdang Health Technology Group Analyst Price Targets→

Non-cyclical consumption Stocks

Dingdong (Cayman) Limited ADRDimed SA Distribuidora de MedicamentosDino PolskaDiligent IndustriesDiplomat HoldingsDigital CommoditiesDis-Chem PharmaciesDiana Tea CoDistilDIAMOND FOOD INDONESIA Tbk PTDistribuidora Internacional de AlimentacionDiamond Estates Wines & SpiritAll Stocks A–Z →